Randomized, phase II, placebo-controlled trial of onartuzumab and/or bevacizumab in combination with weekly paclitaxel in patients with metastatic triple-negative breast cancer

Veronique C Dieras, Mario Campone, Denise Aysel Yardley et al. · Annals of Oncology · 2015

Cited by 70 works. doi:10.1093/annonc/mdv263

Authors

References